Dennis C. Turk

Dennis C. Turk

Auto-generated profile, based on publicly available information

Dennis C. Turk

University of Washington, WA, United States

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2011 in The Lancet
Verified
Journal Article
Closed access
DTDennis C Turk
Dennis C Turk
HWHilary D Wilson
Hilary D Wilson
ACAlex Cahana
Alex Cahana

1 July 2013 in British Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
EDE. J. Dansie
E. J. Dansie
DTD. C. Turk
D. C. Turk
Chronic pain is a public health concern affecting 20–30% of the population of Western countries. Although there have been many scientific advances in the understanding of the neurophysiology of pain, precisely assessing and diagnosing a patient's chronic pain problem is not straightforward or well-defined. How chronic pain is conceptualized influences how pain is evaluated and the factors considered when making a chronic pain diagnosis. There is no one-to-one relationship between the amount or type of organic pathology and pain intensity, but instead, the chronic pain experience is shaped by a myriad of biomedical, psychosocial (e.g. patients' beliefs, expectations, and mood), and behavioural factors (e.g. context, responses by significant others). Assessing each of these three domains through a comprehensive evaluation of the person with chronic pain is essential for treatment decisions and to facilitate optimal outcomes. This evaluation should include a thorough patient history and medical evaluation and a brief screening interview where the patient's behaviour can be observed. Further assessment to address questions identified during the initial evaluation will guide decisions as to what additional assessments, if any, may be appropriate. Standardized self-reported instruments to evaluate the patient's pain intensity, functional abilities, beliefs and expectations, and emotional distress are available, and can be administered by the physician, or a referral for in depth evaluation can be made to assist in treatment planning.

1 September 2016 in The Journal of Pain
Verified
Journal Article
Closed access
DTDennis C. Turk
Dennis C. Turk
RFRoger B Fillingim
Roger B Fillingim
RORichard Ohrbach
Richard Ohrbach
KPKushang V. Patel
Kushang V. Patel

7 April 2016 in Pain
Verified
Journal Article
Closed access
ATAnn M. Taylor
Ann M. Taylor
KPKristine Phillips
Kristine Phillips
KPKushang V. Patel
Kushang V. Patel
DTDennis C. Turk
Dennis C. Turk
RDRobert H. Dworkin
Robert H. Dworkin
JWJames Witter
James Witter
Although pain reduction is commonly the primary outcome in chronic pain clinical trials, physical functioning is also important. A challenge in designing chronic pain trials to determine efficacy and effectiveness of therapies is obtaining appropriate information about the impact of an intervention on physical function. The Initiative on Methods, Measurement, and Pain Assessment in Clinical Trials (IMMPACT) and Outcome Measures in Rheumatology (OMERACT) convened a meeting to consider assessment of physical functioning and participation in research on chronic pain. The primary purpose of this article is to synthesize evidence on the scope of physical functioning to inform work on refining physical function outcome measurement. We address issues in assessing this broad construct and provide examples of frequently used measures of relevant concepts. Investigators can assess physical functioning using patient-reported outcome (PRO), performance-based, and objective measures of activity. This article aims to provide support for the use of these measures, covering broad aspects of functioning, including work participation, social participation, and caregiver burden, which researchers should consider when designing chronic pain clinical trials. Investigators should consider the inclusion of both PROs and performance-based measures as they provide different but also important complementary information. The development and use of reliable and valid PROs and performance-based measures of physical functioning may expedite development of treatments, and standardization of these measures has the potential to facilitate comparison across studies. We provide recommendations regarding important domains to stimulate research to develop tools that are more robust, address consistency and standardization, and engage patients early in tool development.

2 July 2015 in Current Rheumatology Reviews
Verified
Journal Article
Closed access
PDF file
LALeah M. Adams
Leah M. Adams
DTDennis C. Turk
Dennis C. Turk
Central sensitivity syndromes (CSSs) represent a heterogeneous group of disorders (e.g., fibromyalgia [FM], irritable bowel syndrome [IBS], chronic headache, temporomandibular disorders [TMDs], pelvic pain syndromes) that share many common symptoms, with persistent pain being the most prominent feature. Although the etiology and pathophysiology of CSSs are currently incompletely understood, central sensitization has emerged as one of the significant mechanisms. Given that there are currently no known cures for CSSs, people living with these disorders must learn to cope with and manage their symptoms throughout their lives. Medical interventions alone have not proven to be sufficient for helping people with CSSs manage their symptoms. A biopsychosocial perspective that considers the ways that biological, psychological, and social factors work independently and jointly to affect a person’s experience is the most effective conceptualization and guide for effective treatment. In this article, we discuss several psychological and social features that may influence the experience of a person with CSS and their symptom management, regardless of their specific diagnosis. We highlight the longitudinal aspect of adjustment to illness, the distinction between psychosocial factors as causes of symptoms versus modifiers and perpetuators of symptoms, dispel the notion that all patients with the same diagnosis are a homogeneous group (the “patient-uniformity myth”), and acknowledge the importance of environmental and situational context on symptom management for individuals with any CSS.

1 October 2015 in The Journal of Pain
Verified
Journal Article
Closed access
DTDennis C. Turk
Dennis C. Turk
RDRobert H. Dworkin
Robert H. Dworkin
JTJeremiah J. Trudeau
Jeremiah J. Trudeau
CBCarmela Benson
Carmela Benson
DBDavid M. Biondi
David M. Biondi
MKMyoung Kim
Myoung Kim